Autologous Tumor Membrane Vesicles Vaccine Clinical Trials

1 actively recruiting trial across 1 location

Also known as: Autologous TDMV-derived Vaccine, Autologous TMV Vaccine, Autologous TMV-based Vaccine, Autologous Tumor-derived Membrane Vesicles Vaccine

Filter by location:

Atlanta, Georgia1 trial

TMV Vaccine Therapy Alone and With Pembrolizumab for the Treatment of Recurrent and/or Metastatic Head and Neck Squamous Cell Cancer

Emory University Hospital Midtown

Phase 1

Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.

This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.